Investor
Boehringer Ingelheim Venture Fund
Corporate VC
Key details
- Profile type
- Organization
- Geography
- Unknown / Other
- Stage
- 2. Prototype, 3. Early Revenue, 4. Scaling, 5. Growth
- Sector
- protein, therapeutic, therapeutics, drugs, metabolomics, drug, cell therapy, cannabis, medicines, medicine, psychedelic, transcriptomics, life sciences, biotech, bio, metabolites, psychedelics, CBD, life-science, life science, in vitro diagnostics, pharma, CGT, gene therapy, celle therapy, lifescience, IVD, proteomics, life sciences tools, mRNA, biopharma, molecules, pharmaceuticals, lifesciences, biomarkers, genomics
- Invests in
- ["Austria","Belgium","Canada","China","France","Germany","Israel","Portugal","Singapore","Spain","Sweden","Switzerland","UK","USA"]
- Investment size
- N/A
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.
Check current details